"Werner Siemens Imaging Center"
- Funding Agency: Werner Siemens-Foundation, Zug, Switzerland
- Applicant: Prof. Dr. Bernd Pichler
- Funding period: 2024 – 2033 (3. funding period)
"Biologicals Development Center - BioDev Center"
- Funding Agency: MWK
- Applicant: Prof. Dr. Ulrich Rothbauer, Prof. Dr. Bernd Pichler
- Funding period: 2023 – 2027
"Mapping Tumor Metabolic Aggressiveness with hybrid PET/MR Shift Reagents In Vivo"
- Funding Agency: DFG
- Applicant: Prof. Dr. André Martins
- Funding period: 2023 – 2026
"In Vivo PET-Bildgebung von 5HT2A- und AMPA-Rezeptoren im Gehirn"
- Funding Agency: Carl Zeiss Foundation
- Applicant: Prof. Dr. Kristina Herfert
- Funding period: 2023 – 2024
"Erkennung, Monitoring und Prognose von multiplen COVID-19 Langzeitfolgen (Post-COVID-Syndrom) -REMOLCO-"
- Funding Agency: BMBF
- Applicant: Dr. Chrsitoph Trautwein
- Funding period: 2021 – 2024
"Selective PET tracers for pathological tau and α-synuclein aggregates"
- Funding Agency: Michael J. Fox Foundation
- Applicant: Prof. Dr. Kristina Herfert
- Funding period: 2021 – 2023
"Multimodal preclinical imaging of Aspergillus fumigatus invasion and treatment"
- Funding Agency: DFG
- Applicant: Dr. Nicolas Bézière, Prof. Matthias Gunzer (Essen)
- Funding period: 2023 – 2026
"Real-time Imaging of gut microbiome modulation"
- Funding Agency: DFG EXC2124 (Exzellenzcluster CMFI)-Collaborative Research Grant
- Applicant: Dr. Nicolas Bézière, Prof. Dr. Lisa Maier
- Funding period: 2022 – 2025
"Cellular Senescence Network: New Imaging Tools for Arthritis Imaging"
- Funding Agency: National Institutes of Health
- Applicant: Dr. Nicolas Bézière, Prof. Dr. Heike Daldrup-Link (Stanford Medical School, USA)
- Funding period: 2021 – 2025
"In vivo staging alkoholischer und nicht-alkoholischer Lebererkrankungen"
- Funding Agency: DFG
- Applicant: Dr. Andreas Schmid
- Funding period: 2021 – 2024
"Assessment of the therapeutic response of L-DOS47 in several CEACAM6 expressing cancer models with advanced preclinical metabolic imaging"
- Funding Agency: Helix Biopharma (scientific cooperation)
- Applicant: Prof. Dr. André Martins, Dr. Manfred Kneilling
- Funding period: 2022 – 2024
"Dr. K. H. Eberle Forschungspreis 2020"
- Funding Agency: Dr. K. H. Eberle Foundation
- Applicant: Prof. Dr. André Martins, Dr. Sabrina Hoffmann
- Funding period: 2021 – 2022
- Funding Agency: Alexander von Humboldt Foundation
- Applicant: Prof. Dr. André Martins
- Funding period: 2020 – 2025
"Development of the Human Dynamic Neurochemical Connectome Scanner"
- Funding Agency: National Institutes of Health
- Applicant: Prof. Dr. Bernd Pichler, Dr. Fabian Schmidt
- Funding period: 2020 – 2025
"Werner Siemens Imaging Center"
- Funding Agency: Werner Siemens-Foundation, Zug, Switzerland
- Applicant: Prof. Dr. Bernd Pichler
- Funding period: 2016 – 2023 (2. funding period)
"Image-Guided and Functionally Instructed Tumor Therapies (iFIT)"
- Funding Agency: DFG - Excellence Strategy by the German Federal and State Governments
- Applicants: Prof. Dr. Lars Zender, Prof. Dr. Bernd Pichler, Prof. Dr. Hans-Georg Rammensee
- Funding period: 2019 – 2025
- Funding Agency: EU
- Principal Investigators: Prof. Dr. Bernd Pichler, Dr. Manfred Kneilling
- Funding period: 2019 – 2024
- Subproject C03: "Impact of reactive oxygen species and NF-kB signaling during hapten- induced skin inflammation"
- Funding Agency: DFG
- Principal Investigators: Prof. Dr. Bernd Pichler, Dr. Manfred Kneilling
- Funding period (2. funding period): 01.07.2019-30.06.2023